Evaluation of the chylomicron‐TG to VLDL‐TG ratio for type I hyperlipoproteinemia diagnostic-Reference-Cited by-同舟云学术

Evaluation of the chylomicron‐TG to VLDL‐TG ratio for type I hyperlipoproteinemia diagnostic

Published:2020-08-11 Issue:12 Volume:50 Page:
ISSN:0014-2972
Container-title:European Journal of Clinical Investigation
language:en
Short-container-title:Eur. J. Clin. Invest.

Author:

Rioja José¹^ORCID,Ariza María‐José¹,García‐Casares Natalia¹,Coca‐Prieto Inmaculada²,Arrobas Teresa³,Muñiz‐Grijalvo Ovidio⁴,Mangas Alipio⁵,Ibarretxe Daiana⁶,Sánchez‐Chaparro Miguel Ángel¹⁷,Valdivielso Pedro¹⁷^ORCID

Affiliation:

1. Lipids and Atherosclerosis Laboratory Department of Medicine and Dermatology Centro de Investigaciones Médico Sanitarias (CIMES) Instituto de Investigación Biomédica de Málaga (IBIMA) University of Málaga Málaga Spain

2. Internal Medicine Unit Ciudad Real General Hospital Ciudad Real Spain

3. Clinical Chemistry Unit Virgen Macarena Hospital Sevilla Spain

4. Internal Medicine Department UCERV‐UCAMI University Hospital Virgen del Rocío Sevilla Spain

5. Internal Medicine Department School of Medicine Institute of Research and Innovation in Biomedical Sciences (INiBICA) University Hospital Puerta del Mar University of Cadiz Cádiz Spain

6. Vascular Medicine and Metabolism Unit, Research Unit on Lipids and Atherosclerosis Sant Joan University Hospital Universitat Rovira i Virgili IISPV CIBERDEM Reus Spain

7. Lipid Unit University Hospital Virgen de la Victoria Málaga Spain

Funder

Junta de Andalucía

Publisher

Wiley

Subject

Clinical Biochemistry,Biochemistry,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/eci.13345

Reference29 articles.

1. Editorial

2. Diagnosis and Management of Type I and Type V Hyperlipoproteinemia

3. Chylomicronemia Syndrome: Interaction of Genetic and Acquired Hypertriglyceridemia

4. Characterization of a new case of autoimmune type I hyperlipidemia: long‐term remission under immunosuppressive therapy;Pruneta V;J Clin Endocrinol Metab,1997

5. GPIHBP1 autoantibodies in a patient with unexplained chylomicronemia

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pancreatic and cardiometabolic complications of severe hypertriglyceridaemia;Current Opinion in Lipidology;2024-06-06

2. Validation of the familial chylomicronaemia syndrome (FCS) score in an ethnically diverse cohort from UK FCS registry: Implications for diagnosis and differentiation from multifactorial chylomicronaemia syndrome (MCS);Atherosclerosis;2024-04

3. Multifactorial chylomicronemia syndrome;Current Opinion in Endocrinology, Diabetes & Obesity;2023-11-24

4. Evaluation of apolipoprotein A5 variants: A cohort of patients with severe hypertriglyceridemia from Turkiye;Journal of Clinical Lipidology;2023-10

5. Non-alcoholic fatty liver disease in patients with chylomicronemia syndromes;Journal of Clinical Lipidology;2023-07